BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34540700)

  • 1. Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients.
    Shao CY; Yu Y; Li QF; Liu XL; Song HZ; Shen Y; Yi J
    Front Oncol; 2021; 11():736573. PubMed ID: 34540700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
    Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
    Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Zeng Q; Li J; Tan F; Sun N; Mao Y; Gao Y; Xue Q; Gao S; Zhao J; He J
    Ann Surg Oncol; 2021 Sep; 28(9):4893-4904. PubMed ID: 33655361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy.
    Wo Y; Yang H; Zhang Y; Wo J
    Front Oncol; 2019; 9():1385. PubMed ID: 31921643
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection.
    Du F; Sun Z; Jia J; Yang Y; Yu J; Shi Y; Jia B; Zhao J; Zhang X
    J Cancer; 2020; 11(14):4023-4029. PubMed ID: 32368284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
    Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
    Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
    J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
    Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
    Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma.
    Ni X; Ma X; Qiu J; Zhou S; Cheng W; Luo C
    Ann Transl Med; 2021 Feb; 9(4):293. PubMed ID: 33708920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
    Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
    BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
    Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis.
    Wu J; Lu L; Chen H; Lin Y; Zhang H; Chen E; Lin W; Li J; Chen X
    Int J Colorectal Dis; 2021 Sep; 36(9):1981-1993. PubMed ID: 34322745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
    Fan S; Li T; Zhou P; Peng Q; Zhu Y
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and verification of prognostic nomogram for early-onset esophageal cancer.
    Liu X; Guo W; Shi X; Ke Y; Li Y; Pan S; Jin Y; Wang Y; Ruan Q; Ma H
    Bosn J Basic Med Sci; 2021 Dec; 21(6):760-772. PubMed ID: 33823125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.
    Deng J; Ren Z; Wen J; Wang B; Hou X; Xue Z; Chu X
    Cancer Manag Res; 2018; 10():6143-6156. PubMed ID: 30538562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.
    Li X; Xu J; Zhu L; Yang S; Yu L; Lv W; Hu J
    Cancer Med; 2021 Jul; 10(13):4228-4239. PubMed ID: 34128338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.